Table 4.
Therapeutic Approach | Method | Indication | Disadvantages | References |
---|---|---|---|---|
Surgical resection | Complete or partial removal depending on tumor size and location | Localized tumors | [155] | |
Enucleation | Complete removal of the globe | Thickness > 12 mm Basal diameter >18 mm Tumor seeding into the trabecular meshwork Extraocular involvement Melanoma-related glaucoma |
Poor prognosis in case of tumor recurrence | [156,159,160] |
Exenteration | Removal of the globe and its surrounding structures, such as the muscles, fat, nerves, and eyelid | Thickness > 12 mm Basal diameter >18 mm Multifocal or recurrent disease Painful eye Extraocular involvement |
Poor prognosis in case of tumor recurrence | [157,158] |
Radiation therapy | Plaque brachytherapy: Localized application of internal radiation through plaque (containing radioctive source) suturing on episclera. | Small and medium sized tumors | Associated with radiation-induced complications, such as:
Contraindicated in tumors < 2 mm from the optic disc and large tumors Limited adaptability of the applicator to the area, leading to increased radiation exposure |
[161,162] |
Proton beam radiotherapy: Tantalum marker (beam) placement within the tumor for direct radiation for 4 days | Tumor height > 5 mm Narrow base Tumors close to optic nerve Ciliary body involvement greater than one clock hour Extraocular involvement Iris and ciliary body melanomas |
Associated with radiation-induced complications (as mentioned above) Limited availability |
[161,162,163,164,165,166,167] | |
Photocoagulation | Laser used to burn and destroy tumor cells | Small, peripheral tumors | Increased risk of recurrence Increased risk of extension through Buch’s membrane Associated with increased risk for:
|
[154,168] |
Transpupillary thermotherapy | Near-infrared diode laser | Small, accessible tumors | Associated with risks of:
|
[154,169] |